HHS announces funding for development of PTSD treatment, study on emerging mental illness remedies

The Department of Health and Human Services Nov. 12 made two announcements  regarding the development of mental health treatments for veterans and other individuals. The agency announced it would fund up to $4.9 million through the Advanced Research Projects Agency for Health to advance the development of ibogaine as a potential treatment for post-traumatic stress disorder and other serious mental illnesses for veterans and others. HHS also announced that the National Institute of Mental Health issued a funding notice of $20 million to support the development of a research network to study rapid-acting psychotropic interventional drugs, such as ketamine, esketamine, psilocybin and other emerging treatments for serious mental illnesses. The agency said award recipients will be announced in the summer of 2027.